Video

Stacey Cofield, PhD, of NARCOMS

Publish date: October 19, 2015

At ECTRIMS 2015, Dr. Cofield discussed gender differences in attitudes toward marijuana as a treatment for symptoms of MS.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Fampridine May Improve Walking and Quality of Life in Patients With MS
ICYMI Multiple Sclerosis
Dimethyl Fumarate Shows Efficacy in Patients Newly Diagnosed With MS
ICYMI Multiple Sclerosis
Anti-LINGO-1 Monoclonal Antibody BIIB033 Improves Optic Nerve Latency in Acute Optic Neuritis
ICYMI Multiple Sclerosis
Do Attitudes Toward Marijuana Differ Between Men and Women With MS?
ICYMI Multiple Sclerosis
Long-Term Efficacy of Fingolimod Reinforced by New NEDA-4 Analysis
ICYMI Multiple Sclerosis
Minocycline for MS?
ICYMI Multiple Sclerosis
Daclizumab Reduces Brain Volume Loss, Compared With Interferon
ICYMI Multiple Sclerosis
Cannabinoid Spray Effectively Relieves MS-Related Spasticity
ICYMI Multiple Sclerosis
Anti-JCV Antibody Index and L-Selectin Hone PML Risk Stratification During Natalizumab Therapy
ICYMI Multiple Sclerosis
Sodium Channel Blockade With Phenytoin Has a Neuroprotective Effect After Acute Optic Neuritis
ICYMI Multiple Sclerosis

Related Articles